SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
When do Spironolactone And Hydrochlorothiazide patents expire, and what generic alternatives are available?
Spironolactone And Hydrochlorothiazide is a drug marketed by Ascot, Chartwell Rx, Mutual Pharm, Mylan, Purepac Pharm, Sun Pharm Industries, Superpharm, and Watson Labs. and is included in eight NDAs.
The generic ingredient in SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; spironolactone. There are thirty-two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; spironolactone profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE?
- What are the global sales for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE?
- What is Average Wholesale Price for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE?
Summary for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 8 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 5 |
| Clinical Trials: | 9 |
| Patent Applications: | 30 |
| What excipients (inactive ingredients) are in SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE? | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE excipients list |
| DailyMed Link: | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE at DailyMed |
Recent Clinical Trials for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Chiang Mai University | Phase 3 |
| Medical University of Bialystok | N/A |
| Shanghai Jiao Tong University School of Medicine | Phase 4 |
See all SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE clinical trials
Pharmacology for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
| Drug Class | Aldosterone Antagonist Thiazide Diuretic |
| Mechanism of Action | Aldosterone Antagonists |
| Physiological Effect | Increased Diuresis |
US Patents and Regulatory Information for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ascot | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; spironolactone | TABLET;ORAL | 088025-001 | Nov 23, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Superpharm | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; spironolactone | TABLET;ORAL | 089137-001 | Aug 26, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; spironolactone | TABLET;ORAL | 086513-001 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; spironolactone | TABLET;ORAL | 087398-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
